◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

3B Blackbio Dx Limited (3BBLACKBIO) Financial History

Name: 3B Blackbio Dx Limited (3BBLACKBIO) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-09-20

3B Blackbio Dx Limited (3BBLACKBIO) operates in the Biotechnology industry and is headquartered in Bhopal, India with about 86 employees. In the fiscal year ended 2026-03-31, 3BBLACKBIO reported ₹1.4B in revenue and ₹599M in net income.

3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India.

Interactive charts & full statements →

3BBLACKBIO Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹1.4B	₹965M	₹741M	₹618M	—
Gross Profit	₹1.1B	₹708M	₹523M	₹439M	—
Operating Income (EBIT)	₹552M	₹493M	₹322M	₹286M	—
Net Income	₹599M	₹477M	₹321M	₹259M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3BBLACKBIO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹335M	₹354M	₹504M	₹339M	₹222M
Gross Profit	₹259M	₹279M	₹365M	₹246M	₹167M
Operating Income (EBIT)	₹72M	₹46M	₹210M	₹142M	₹116M
Net Income	₹95M	₹96M	₹217M	₹147M	₹126M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3BBLACKBIO Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹34M)	(₹26M)	(₹22M)	(₹44M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3BBLACKBIO Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹3.8B	₹3.0B	₹2.5B	₹2.1B	—
Total Liabilities	₹464M	₹247M	₹226M	₹182M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3BBLACKBIO viewer.

Other Companies in Biotechnology

SCNI · Scinai Immunotherapeutics Ltd. — $1 million
PTP · Pentixapharm Holding AG — €1 million
BDRX · Biodexa Pharmaceuticals Plc — $1 million
APM · Aptorum Group Ltd — $1 million
6132 · HJ Science Co., Ltd.
BIOCON · Biocon Limited — ₹627 billion
ANTHEM · Anthem Biosciences Limited — ₹522 billion
ABBV · AbbVie — $466 billion

← 3999 All “0-9” companies 3D3D →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.